Results 151 to 160 of about 919 (164)

Vitreous Levels of Active Ocriplasmin Following Intravitreal Injection: Results of an Ascending Exposure Trial

Investigative Ophthalmology and Visual Science, 2013
Peter Stalmans, Aniz Girach
exaly  

Ocriplasmin

Reactions Weekly, 2020
openaire   +1 more source

Ocriplasmin

Reactions Weekly, 2017
  +4 more sources

Ocriplasmin: A Review of Its Use in Patients With Symptomatic Vitreomacular Adhesion

Drugs, 2013
Yahiya Y Syed, Sohita Dhillon
exaly  

Ocriplasmin Use for Vitreomacular Traction and Macular Hole: A Meta-Analysis and Comprehensive Review on Predictive Factors for Vitreous Release and Potential Complications

Graefe's Archive for Clinical and Experimental Ophthalmology, 2016
Michael Miligkos, Irini Chatziralli, Sobha Sivaprasad   +2 more
exaly  

Ocriplasmin for Treatment of Vitreomacular Traction: An Update

Ophthalmology and Therapy, 2016
Julia Haller, Mohammed Ali Khan
exaly  

Mechanism of Inactivation of Ocriplasmin in Porcine Vitreous

Biophysical Chemistry, 2012
Marc D de Smet, Marc Vanhove
exaly  

Complications of Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole: A Prospective Spectral-Domain Optical Coherence Tomography Study

Cutaneous and Ocular Toxicology, 2016
Irini Chatziralli, Panagiotis Theodossiadis, George P Theodossiadis   +2 more
exaly  

Acute Loss of Vision After an Intravitreal Injection Ocriplasmin: A Functional Evolutionary Study for 1-Year Follow-Up

Documenta Ophthalmologica, 2015
Manuel Bande, Francisco Gómez-Ulla
exaly  

Understanding the Adverse Effects of Ocriplasmin—Reply

JAMA Ophthalmology, 2015
Michael D, Tibbetts, Elias, Reichel, Andre J, Witkin   +2 more
openaire   +2 more sources